Goldman Sachs Group Inc Macrogenics Inc Transaction History

Goldman Sachs Group Inc

  • $596 Billion
  • Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Macrogenics Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 197,696 shares of MGNX stock, worth $343,991. This represents 0.0% of its overall portfolio holdings.

Number of Shares
197,696
Previous 197,696 -0.0%
Holding current value
$343,991
Previous $251,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$1.26 - $3.49 $193,334 - $535,505
-153,440 Reduced 43.7%
197,696 $251,000
Q4 2024

Feb 11, 2025
BUY
$3.18 - $4.46 $390,154 - $547,197
122,690 Added 53.71%
351,136 $1.14 Million
Q3 2024

Nov 14, 2024
SELL
$3.0 - $5.55 $744,240 - $1.38 Million
-248,080 Reduced 52.06%
228,446 $751,000
Q2 2024

Aug 13, 2024
BUY
$3.31 - $18.51 $430,965 - $2.41 Million
130,201 Added 37.6%
476,526 $2.03 Million
Q1 2024

May 15, 2024
SELL
$9.77 - $21.47 $2.65 Million - $5.83 Million
-271,638 Reduced 43.96%
346,325 $5.1 Million
Q4 2023

Feb 13, 2024
BUY
$4.48 - $10.11 $519,254 - $1.17 Million
115,905 Added 23.09%
617,963 $5.94 Million
Q3 2023

May 14, 2024
SELL
$4.48 - $6.19 $519,254 - $717,451
-115,905 Reduced 18.76%
502,058 $2.34 Million
Q3 2023

Nov 14, 2023
BUY
$4.48 - $6.19 $463,285 - $640,120
103,412 Added 25.94%
502,058 $2.34 Million
Q2 2023

May 14, 2024
BUY
$4.62 - $7.54 $310,699 - $507,072
67,251 Added 20.29%
398,646 $2.13 Million
Q2 2023

Aug 14, 2023
BUY
$4.62 - $7.54 $310,699 - $507,072
67,251 Added 20.29%
398,646 $2.13 Million
Q1 2023

May 14, 2024
SELL
$4.82 - $7.24 $832,274 - $1.25 Million
-172,671 Reduced 34.26%
331,395 $2.38 Million
Q1 2023

May 11, 2023
SELL
$4.82 - $7.24 $832,274 - $1.25 Million
-172,671 Reduced 34.26%
331,395 $2.38 Million
Q4 2022

May 14, 2024
BUY
$3.34 - $6.98 $137,043 - $286,396
41,031 Added 8.86%
504,066 $3.38 Million
Q4 2022

Feb 13, 2023
BUY
$3.34 - $6.98 $137,043 - $286,396
41,031 Added 8.86%
504,066 $3.38 Million
Q3 2022

May 14, 2024
SELL
$3.01 - $5.22 $366,527 - $635,639
-121,770 Reduced 20.82%
463,035 $1.6 Million
Q3 2022

Nov 10, 2022
SELL
$3.01 - $5.22 $366,527 - $635,639
-121,770 Reduced 20.82%
463,035 $0
Q2 2022

May 14, 2024
SELL
$2.25 - $9.99 $74,605 - $331,248
-33,158 Reduced 5.37%
584,805 $1.73 Million
Q2 2022

Aug 15, 2022
BUY
$2.25 - $9.99 $575,700 - $2.56 Million
255,867 Added 77.79%
584,805 $1.73 Million
Q1 2022

May 16, 2022
SELL
$8.12 - $16.9 $607,993 - $1.27 Million
-74,876 Reduced 18.54%
328,938 $2.9 Million
Q4 2021

Feb 14, 2022
BUY
$15.91 - $21.88 $1.47 Million - $2.03 Million
92,615 Added 29.76%
403,814 $6.48 Million
Q3 2021

Nov 10, 2021
BUY
$19.74 - $28.7 $6.14 Million - $8.93 Million
311,199 New
311,199 $6.52 Million

Others Institutions Holding MGNX

# of Institutions
133
Shares Held
54M
Call Options Held
45.1K
Put Options Held
143K
View Full List

About MACROGENICS INC

MGNX Quotes by TradingView
  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $107M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email